RIPPLY1 suppresses cancer cell stemness via targeting TBX19 in CTNNB1-mutated hepatocellular carcinoma.

Journal:
Hepatology
Published:
DOI:
10.1097/hep.0000000000001483
Affiliations:
6
Authors:
12
Go to article
Institutions Authors Share
Ruijin Hospital, SJTU, China
8.000000
 0.67
Drum Tower Hospital, China
2.500000
 0.21
Anhui Medical University (AHMU), China
1.000000
 0.08
State Key Laboratory of Pharmaceutical Biotechnology, NJU, China
0.500000
 0.04
Interested in Oncology and Carcinogenesis?